^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Endometrial Cancer
    Drug:cisplatin (DNA synthesis inhibitor) +
    paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) +
    doxorubicin hydrochloride (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Endometrial carcinoma: Other recommended regimens…cisplatin/doxorubicin/paclitaxel